Intervention trial of beta-cryptoxanthin-rich satsuma mandarin juice

Intervention trial of beta-cryptoxanthin-rich satsuma mandarin juice - Intervention trial of beta-cryptoxanthin-rich satsuma mandarin juice

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013579

Enrollment

120

Registered

2014-03-31

Start date

2014-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis metabolic syndrome

Interventions

Beta-cryptoxanthin-rich (4mg) satsuma mandarin juice for 12 weeks Non beta-cryptoxanthin (0mg) satsuma mandarin juice for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Participants of specified health check-up

Exclusion criteria

Exclusion criteria: 1) Eat satsuma mandarin everyday between October and February. 2) History of stroke, myocardial infarction, cancer and aneurism. 3) Being treated with diet therapy by physician. 4) Plan to quit smoking within 3 months. 5) Taking antihypertensives.

Design outcomes

Primary

Measure	Time frame
1) pulse wave velocity 2) MDA-oxLDL	—

Secondary

Measure	Time frame
1) hsCRP,IL-6 2) adiponectin 3) insulin,FBS,HOMA index,HbA1c 4) blood pressure 5) AST,ALT,GGTP 6) LDL-C,HDL-C,TG	—

Countries

Japan

Contacts

Public ContactNAKAMURA Mieko

Hamamatsu University School of Medicine Department of Community Health and Preventive Medicine

miekons@hama-med.ac.jp053-435-2333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026